Q--Base + 4 OY DX-Melanoma Testing

Business Sources Sought This is a Sources Sought announcement seeking any size Business responses in order to determine adequate competition in the acquisition. The Department of Veterans Affairs (NCO 21) intends to procure Cutaneous DecisionDx-Melanoma test. The DecisionDx-Melanoma test is a predictor test for metastatic risk. The gene expression profile (GEP) test is designed to identify high risk Stage I and Stage II patients based on biological information from 31 genes within their tumor tissue. This information will aid the physician and patient to make informed decisions about how aggressively to manage the disease for the Northern California VA health Care System. The services to be performed IAW attached performance work statement: The designated NAICS Code is 621511 Medical Laboratory Testing, size standard is $32.5 Million. Your response shall include the following information: Size of company (i.e., 8(a), HUBZONE, WOSB, Veteran Owned, Small Disadvantaged Business, Service Disabled Veteran Owned, etc.), Relevant past performance on same/similar work dating back to the last five years and your company s capability to do this type of work. Documentation of technical expertise and capability must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. It is imperative that business concerns responding to this sources sought articulate their capabilities clearly and adequately. The information should be sent to Department of Veterans Affairs via e-mail [email protected] by COB 17 April 2019. Any questions can be directed to David Alvarez at 916-923-4588. IF A SOLICITATION IS ISSUED IT WILL BE ANNOUNCED AT A LATER DATE, and all interested parties must respond to that solicitation announcement separately from the responses to this announcement. No contract will be awarded as a result of this announcement and No reimbursement will be made for any costs associated with providing information in response to this announcement. Â